425981005: Aliskiren fumarate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\...

\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Renin inhibitor\Aliskiren fumarate (substance)

\Hydrolase inhibitor\Peptide hydrolase inhibitor\Proteinase inhibitor\Aspartic proteinase inhibitor\Renin inhibitor\Aliskiren fumarate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Renin inhibitor\Aliskiren fumarate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Tetrazole (substance)\Aliskiren fumarate (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Tetrazole (substance)\Aliskiren fumarate (substance)
\Organic compound\Organic nitrogen compound\Azole\Tetrazole (substance)\Aliskiren fumarate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Aliskiren fumarate (substance)	Is a	Aliskiren (substance)	false	Inferred relationship	Some
Aliskiren fumarate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Renin inhibitor (disposition)	true	Inferred relationship	Some
Aliskiren fumarate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Aliskiren (substance)	true	Inferred relationship	Some
Aliskiren fumarate (substance)	Is a	Renin inhibitor	true	Inferred relationship	Some
Aliskiren fumarate (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Aliskiren fumarate (substance)	Is a	Tetrazole (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aliskiren fumarate (substance)	Inferred relationship	Some
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aliskiren fumarate (substance)	Inferred relationship	Some
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Aliskiren (as aliskiren fumarate) 150 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	1
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	3
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	3
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	3
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	2
Aliskiren (as aliskiren fumarate) 300 mg and hydrochlorothiazide 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	2
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	2
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aliskiren fumarate (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2663055010	Aliskiren fumarate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2675070010	Aliskiren fumarate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3761566015	Aliskiren hemifumarate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
421000188115	aliskirène hémifumarate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
50015751000188118	fumarate d'aliskirène	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module